These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 16611199)

  • 1. Indications for propensity scores and review of their use in pharmacoepidemiology.
    Glynn RJ; Schneeweiss S; Stürmer T
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):253-9. PubMed ID: 16611199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating effects of nursing intervention via propensity score analysis.
    Qin R; Titler MG; Shever LL; Kim T
    Nurs Res; 2008; 57(6):444-52. PubMed ID: 19018219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs.
    Stürmer T; Wyss R; Glynn RJ; Brookhart MA
    J Intern Med; 2014 Jun; 275(6):570-80. PubMed ID: 24520806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matching by propensity score in cohort studies with three treatment groups.
    Rassen JA; Shelat AA; Franklin JM; Glynn RJ; Solomon DH; Schneeweiss S
    Epidemiology; 2013 May; 24(3):401-9. PubMed ID: 23532053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study.
    Austin PC; Grootendorst P; Anderson GM
    Stat Med; 2007 Feb; 26(4):734-53. PubMed ID: 16708349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods to control for unmeasured confounding in pharmacoepidemiology: an overview.
    Uddin MJ; Groenwold RH; Ali MS; de Boer A; Roes KC; Chowdhury MA; Klungel OH
    Int J Clin Pharm; 2016 Jun; 38(3):714-23. PubMed ID: 27091131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Core Concepts in Pharmacoepidemiology: Quantitative Bias Analysis.
    Brown JP; Hunnicutt JN; Ali MS; Bhaskaran K; Cole A; Langan SM; Nitsch D; Rentsch CT; Galwey NW; Wing K; Douglas IJ
    Pharmacoepidemiol Drug Saf; 2024 Oct; 33(10):e70026. PubMed ID: 39375940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information.
    Stürmer T; Glynn RJ; Rothman KJ; Avorn J; Schneeweiss S
    Med Care; 2007 Oct; 45(10 Supl 2):S158-65. PubMed ID: 17909375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the E-value in the presence of bias amplification: a simulation study.
    Barrette E; Higuera L; Wherry K
    BMC Med Res Methodol; 2024 Mar; 24(1):79. PubMed ID: 38539082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods.
    Stürmer T; Joshi M; Glynn RJ; Avorn J; Rothman KJ; Schneeweiss S
    J Clin Epidemiol; 2006 May; 59(5):437-47. PubMed ID: 16632131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propensity Score Weighting and Trimming Strategies for Reducing Variance and Bias of Treatment Effect Estimates: A Simulation Study.
    Stürmer T; Webster-Clark M; Lund JL; Wyss R; Ellis AR; Lunt M; Rothman KJ; Glynn RJ
    Am J Epidemiol; 2021 Aug; 190(8):1659-1670. PubMed ID: 33615349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the Utility of Coarsened Exact Matching for Pharmacoepidemiology Using Real and Simulated Claims Data.
    Ripollone JE; Huybrechts KF; Rothman KJ; Ferguson RE; Franklin JM
    Am J Epidemiol; 2020 Jun; 189(6):613-622. PubMed ID: 31845719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the ability of double-robust estimators to correct bias in propensity score matching analysis. A Monte Carlo simulation study.
    Nguyen TL; Collins GS; Spence J; Devereaux PJ; Daurès JP; Landais P; Le Manach Y
    Pharmacoepidemiol Drug Saf; 2017 Dec; 26(12):1513-1519. PubMed ID: 28984050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing causal treatment effect estimation when using large observational datasets.
    John ER; Abrams KR; Brightling CE; Sheehan NA
    BMC Med Res Methodol; 2019 Nov; 19(1):207. PubMed ID: 31726969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of prior event rate ratio adjustment method in pharmacoepidemiology: a simulation study.
    Uddin MJ; Groenwold RH; van Staa TP; de Boer A; Belitser SV; Hoes AW; Roes KC; Klungel OH
    Pharmacoepidemiol Drug Saf; 2015 May; 24(5):468-77. PubMed ID: 25410590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An application of propensity score matching using claims data.
    Seeger JD; Williams PL; Walker AM
    Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):465-76. PubMed ID: 15651087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tutorial on the use of instrumental variables in pharmacoepidemiology.
    Ertefaie A; Small DS; Flory JH; Hennessy S
    Pharmacoepidemiol Drug Saf; 2017 Apr; 26(4):357-367. PubMed ID: 28239929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Cautionary Note on Using Propensity Score Calibration to Control for Unmeasured Confounding Bias When the Surrogacy Assumption Is Absent.
    Wan F
    Am J Epidemiol; 2024 Feb; 193(2):360-369. PubMed ID: 37759344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What's new in trial design: propensity scores, equivalence, and non-inferiority.
    Myles PS
    J Extra Corpor Technol; 2009 Dec; 41(4):P6-10. PubMed ID: 20092080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the c-statistic in variable selection for propensity score models.
    Westreich D; Cole SR; Funk MJ; Brookhart MA; Stürmer T
    Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):317-20. PubMed ID: 21351315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.